1st Circ. Says Apellis Disclosures Weren't 'Half-Truths'
By Craig Clough · August 19, 2026, 10:07 PM EDT
A First Circuit panel on Wednesday affirmed the dismissal of a securities fraud lawsuit accusing Apellis Pharmaceuticals and some of its top executives of misleading investors about the safety testing of...
To view the full article, register now.